Change in Impulsivity is Prospectively Associated with Treatment Outcomes for Binge-Eating Disorder
| Autor: | Carlos M. Grilo, Ralitza Gueorguieva, Rebecca G. Boswell |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Fluoxetine
business.industry medicine.medical_treatment Impulsivity medicine.disease Article Cognitive behavioral therapy Psychiatry and Mental health Eating disorders Binge-eating disorder medicine medicine.symptom business Body mass index Applied Psychology Depression (differential diagnoses) Psychopathology medicine.drug Clinical psychology |
| Zdroj: | Psychol Med |
| ISSN: | 0033-2917 |
| Popis: | BackgroundImpulsivity may be a process underlying binge-eating disorder (BED) psychopathology and its treatment. This study examined change in impulsivity during cognitive-behavioral therapy (CBT) and/or pharmacological treatment for BED and associations with treatment outcomes.MethodsIn total, 108 patients with BED (NFEMALE= 84) in a randomized placebo-controlled clinical trial evaluating the efficacy of CBT and/or fluoxetine were assessed before treatment, monthly throughout treatment, at post-treatment (16 weeks), and at 12-month follow-up after completing treatment. Patients completed established measures of impulsivity, eating-disorder psychopathology, and depression, and were measured for height and weight [to calculate body mass index (BMI)] during repeated assessments by trained/monitored doctoral research-clinicians. Mixed-effects models using all available data examined changes in impulsivity and the association of rapid and overall changes in impulsivity on treatment outcomes. Exploratory analyses examined whether baseline impulsivity predicted/moderated outcomes.ResultsImpulsivity declined significantly throughout treatment and follow-up across treatment groups. Rapid change in impulsivity and overall change in impulsivity during treatment were significantly associated with reductions in eating-disorder psychopathology, depression scores, and BMI during treatment and at post-treatment. Overall change in impulsivity during treatment was associated with subsequent reductions in depression scores at 12-month follow-up. Baseline impulsivity did not moderate/predict eating-disorder outcomes or BMI but did predict change in depression scores.ConclusionsRapid and overall reductions in impulsivity during treatment were associated with improvements in specific eating-disorder psychopathology and associated general outcomes. These effects were found for both CBT and pharmacological treatment for BED. Change in impulsivity may be an important process prospectively related to treatment outcome. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|